Neurocrine Biosciences Appoints Dr. Ingrid Delaet as Chief Regulatory Officer

SAN DIEGO, Sept. 29, 2022 /PRNewswire/ — Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that Dr. Ingrid Delaet will join the company’s executive management team as Chief Regulatory Officer effective October 1, leading the regulatory affairs, quality assurance, medical…

Click here to view original post